Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
688091 Shanghai Yizhong Pharmaceutical
72.810
-1.200-1.62%
Short Name-A
上海谊众药业
Company Name
Shanghai Yizhong Pharmaceutical Co., Ltd.
Listing Date
09/09/2021
Establishment Date
09/10/2009
Chairman
Jingsong Zhou
Legal Representative
Jingsong Zhou
General Manager
Jingsong Zhou
Secretary
Zhou Fang
Employees
122
Province
Shang Hai Shi
Number
021-37190005
Office Address
79 Renqi road, Fengxian district, shanghai
Zip Code
201403
Registered Address
79 Renqi road, Fengxian district, shanghai
Fax
021-37190005-8037
Email
info@yizhongpharma.com
Business License
91310120694192165H
Business
License project: drug production. (for projects that must be approved according to law, business activities can only be carried out with the approval of the relevant departments. The specific business projects shall be subject to the approval documents or permits of the relevant departments.) General projects: engaged in technological development, technical consultation and technical services in the field of medical, pharmaceutical and medical device science and technology. (except for projects that need to be approved according to law, independently carry out business activities according to law on the strength of business license)
Profile
The company is committed to the development of new dosage forms of antineoplastic drugs and related products. The company is committed to the R & D and industrialization of improved new drugs for antineoplastic drugs, with high-tech talents with the background of polymer materials, pharmaceutical preparations and biology, and mastering the core and key technologies for the synthesis of nano-drug carriers and medicinal polymer excipients. The company's main research and development product is paclitaxel micelles. Paclitaxel micelle is an innovative lyophilized powder injection without polyoxyethylene castor oil and methoxy polyethylene glycol 2000-poly (lactide) copolymer as carrier.
Company Overview
The company is committed to the development of new dosage forms of antineoplastic drugs and related products. The company is committed to the R & D and industrialization of improved new drugs for antineoplastic drugs, with high-tech talents with the background of polymer materials, pharmaceutical preparations and biology, and mastering the core and key technologies for the synthesis of nano-drug carriers and medicinal polymer excipients. The company's main research and development product is paclitaxel micelles. Paclitaxel micelle is an innovative lyophilized powder injection without polyoxyethylene castor oil and methoxy polyethylene glycol 2000-poly (lactide) copolymer as carrier.
CEO: Jingsong Zhou
Market: --
Listing Date: 09/09/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist